| HBV | hepatitis B virus |
| HCC | hepatocellular carcinoma |
| CHB | chronic hepatitis B |
| NAs | nucleos(t)ide analogs |
| IFN | interferon |
| cccDNA | covalently closed circular DNA |
| AFP | alpha-fetoprotein |
| PIVKA-II | vitamin K absence or antagonist-II |
| HBcrAg | hepatitis B core-related antigen |
| HBsAg | hepatitis B surface antigen |
| M2BPGi | Mac-2-binding protein glycosylation isomer |
| NTCP | sodium taurocholate co-transporting polypeptide |
| HBeAg | hepatitis B envelope antigen |
| IgM anti-HBc | immunoglobulin M antibody to hepatitis B core antigen |
| IgG anti-HBc | immunoglobulin G antibody to hepatitis B core antigen |
| HBsAg-HQ | high-sensitivity HBsAg assay |
| ICT CLEIA | immune complex transfer chemiluminescence enzyme immunoassay |
| AUROC | the area under the receiver operating characteristic curve |
| BCP | basal core promotor |
| M2BP | Mac-2-binding protein |
| WTA | Wisteria floribunda agglutinin |
| C.O.I. | cutoff index |
| CHC | chronic hepatitis C |
| SVR | sustained virological response |
| BMI | body mass index |